Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Monoclonal antibody CT-P59 shows preclinical efficacy against South African SARS-CoV-2 variant

Researchers in the Republic of Korea (South Korea), The Netherlands, and South Africa have demonstrated the potential of the monoclonal antibody CT-P59 as an effective therapeutic for coronavirus disease 2019 (COVID-19) caused by the South African B.1.351 variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

29 Apr 2021

"COVID-19 diarrhea" depends on inflammatory response that is part of the disease

Researchers in the United States have provided important insights into the pathophysiology of diarrhea that occurs in some cases of coronavirus disease 2019 (COVID-19).

29 Apr 2021

Guidance on diagnosis and management of cerebral venous sinus thrombosis after a COVID-19 vaccine

Last Friday, the Centers for Disease Control and Prevention and the U.S. Food & Drug Administration lifted the pause in administration of the Johnson & Johnson (Janssen) COVID-19 vaccine in the U.S.

29 Apr 2021

Study finds low risk of infection in babies born to mothers tested positive for SARS-CoV-2

Researchers at Karolinska Institutet and the Public Health Agency of Sweden have studied newborn babies whose mothers tested positive for SARS-CoV-2 during pregnancy or childbirth.

29 Apr 2021

Study examines risk phenotypes of diabetes and their association with COVID-19 severity

People with diabetes are at increased risk of developing a severe course of COVID-19 compared to people without diabetes.

29 Apr 2021

Touching contaminated surfaces can transfer SARS-CoV-2 to skin, finds study

Using artificial skin, researchers found that touching surfaces contaminated with SARS-CoV-2 can lead to transfer of virus to the skin.

29 Apr 2021

Researchers characterize a large set of therapeutic antibodies against SARS-CoV-2 variants

A team of scientists from A-Alpha Bio., USA, has recently conducted a large-scale screening of 33 therapeutic antibodies to examine their binding affinity to a number of SARS-CoV-2 variants. The team analyzed the impact of potential mutations in the spike RBD on antibody efficacy.

29 Apr 2021

A ‘dose of hope’? Fact-checking President Joe Biden’s first speech to Congress

In his first speech before Congress, President Joe Biden argued it was time to turn the coronavirus pandemic into a historic opportunity to expand government for the benefit of a wider range of Americans, urging investments in jobs, climate change, child care, infrastructure and more.

29 Apr 2021

Covid forces cohousing communities to examine shared values and relationships

Tensions were running high at PDX Commons, a cohousing community for adults 55 and older in Portland, Oregon. Several people wanted to keep visitors off-site until all 35 residents were vaccinated. Others wanted to open to family and friends for the first time in a year.

29 Apr 2021

Host protein mimicry of SARS-CoV-2 receptor binding motif

In a new study, structural bioinformatics approaches are employed to investigate the potential mimicry of the receptor-binding motif (RBM) of these three coronaviruses, finding that several proteins from both human and non-human sources were similar to each, with implications regarding the mechanism of infection and tropism of SARS-CoV-2.

29 Apr 2021

Is Hong Kong’s fourth wave of COVID-19 due to the Q57H SARS-CoV-2 variant?

A recent article in the Centers for Disease Control and Prevention (CDC)’s Emerging Infectious Diseases reveals that the last of these was probably due to the introduction of a new variant from Nepal. This novel variant had been circulating in the community for about a month before the last outbreak was reported.

29 Apr 2021

COVID-19 vaccination willingness in Australia hinges on public perception of health threat

A new study reports the results of a survey in Australia on vaccine willingness at two points: the first wave in April 2020, and during November of the same year, when cases had dropped significantly.

29 Apr 2021

Risk factors for long COVID-19 in children

A new study describes the risk factors and outcomes of “long COVID-19” in a cohort of children who were hospitalized with COVID-19.

29 Apr 2021

Researchers discover how SARS-CoV-2 hijacks human cell machinery to blunt immune response

Researchers at University of California San Diego School of Medicine have discovered one way in which SARS-CoV-2, the coronavirus that causes COVID-19, hijacks human cell machinery to blunt the immune response, allowing it to establish infection, replicate and cause disease.

29 Apr 2021

Immunocompromised children and young adults may experience prolonged SARS-CoV-2 infection

Children and young adults with compromised immune systems, such as those undergoing cancer treatment, may experience a prolonged period of infection with SARS-CoV-2, the virus that causes COVID-19, and the extended duration of infection may increase the incidence of mutations.

29 Apr 2021

New insights into how South African SARS-CoV-2 variant sacrifices tight binding for antibody evasion

The highly infectious SARS-CoV-2 variant that recently emerged in South Africa, known as B.1.351, has scientists wondering how existing COVID-19 vaccines and therapies can be improved to ensure strong protection.

29 Apr 2021

Study of 180 breastfeeding mothers after mRNA COVID-19 vaccination

Vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, were developed at an unprecedented pace. To date, more than 1 billion vaccine doses have been administered worldwide, many of which messenger RNA (mRNA) based.

29 Apr 2021

Long COVID also affects children, study finds

Older children and children with allergies or asthma were found to have greater odds of having persistent symptoms even months after recovery.

28 Apr 2021

Potent monoclonal antibody shows promise against emerging SARS-CoV-2 variants of concern

In a new study currently available on the bioRxiv* preprint server, a group of US-based researchers developed a panel of neutralizing monoclonal antibodies against SARS-CoV-2 that can block viral attachment to cells – and pinpointed a specific one that can potently neutralize all tested variants of concern.

28 Apr 2021

Safety and efficacy of Pfizer and AstraZeneca COVID-19 vaccines even better than clinical trials predicted

Researchers in the UK and United States have demonstrated the efficacy of one dose of either the Pfizer-BioNTech or Oxford-AstraZeneca vaccine against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a real-world community setting in the UK.

28 Apr 2021

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Monoclonal antibody CT-P59 shows preclinical efficacy against South African SARS-CoV-2 variant

"COVID-19 diarrhea" depends on inflammatory response that is part of the disease

Guidance on diagnosis and management of cerebral venous sinus thrombosis after a COVID-19 vaccine

Study finds low risk of infection in babies born to mothers tested positive for SARS-CoV-2

Study examines risk phenotypes of diabetes and their association with COVID-19 severity

Touching contaminated surfaces can transfer SARS-CoV-2 to skin, finds study

Researchers characterize a large set of therapeutic antibodies against SARS-CoV-2 variants

A ‘dose of hope’? Fact-checking President Joe Biden’s first speech to Congress

Covid forces cohousing communities to examine shared values and relationships

Host protein mimicry of SARS-CoV-2 receptor binding motif

Is Hong Kong’s fourth wave of COVID-19 due to the Q57H SARS-CoV-2 variant?

COVID-19 vaccination willingness in Australia hinges on public perception of health threat

Risk factors for long COVID-19 in children

Researchers discover how SARS-CoV-2 hijacks human cell machinery to blunt immune response

Immunocompromised children and young adults may experience prolonged SARS-CoV-2 infection

New insights into how South African SARS-CoV-2 variant sacrifices tight binding for antibody evasion

Study of 180 breastfeeding mothers after mRNA COVID-19 vaccination

Long COVID also affects children, study finds

Potent monoclonal antibody shows promise against emerging SARS-CoV-2 variants of concern

Safety and efficacy of Pfizer and AstraZeneca COVID-19 vaccines even better than clinical trials predicted

Industry Focus eBook - Infectious Diseases (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Industry Focus eBook - Infectious Diseases (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in